Evidence map›Paper›PMID 27958602›Full record

ArticleActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale2016

Severe to profound deafness may be associated with MYH9-related disease: report of 4 patients.

P Canzi, A Pecci, M Manfrin, E Rebecchi, C Zaninetti, V Bozzi, M Benazzo

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 49 citations in OpenAlex.

  1. The role of cochlear implant positioning on MR imaging quality: a preclinical in vivo study with a novel implant magnet system.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

P CanziDepartment of Otorhinolaryngology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy.
A PecciDepartment of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy.
M ManfrinDepartment of Otorhinolaryngology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy.
E RebecchiDepartment of Otorhinolaryngology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy.
C ZaninettiDepartment of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy.
V BozziDepartment of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy.
M BenazzoDepartment of Otorhinolaryngology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy.
University of Pavia · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MYH9-related disease (MYH9-RD) is a rare genetic syndromic disorder characterised by congenital thrombocytopenia and is associated with the risk of developing progressive sensorineural hearing loss, nephropathy and presenile cataracts during childhood or adult life. All consecutive patients enrolled in the Italian Registry for MYH9-RD with severe to profound deafness were included in a retrospective study. The study population involved 147 Italian patients with MYH9-RD: hearing loss was identified in 52% of cases and only 4 patients (6%) presented severe to profound deafness at a mean age of 33 years. Deafness was associated with mild spontaneous bleeding in all patients and with kidney involvement in 3 cases. Cochlear implantation was carried out in 3 cases with benefit, and no major complications were observed. Diagnosis was performed about 28 years after the first clinical manifestation of MYH9-RD, which was never suspected by an otolaryngologist. The clinical and diagnostic aspects of 4 patients with severe to profound deafness are discussed with a focus on therapeutic implications.

Indexed as

AdultDeafnessFemaleHearing Loss, SensorineuralHumansMaleRetrospective StudiesSeverity of Illness IndexThrombocytopeniaGenetic syndromeHearing lossMYH9

Identifiers

PMID27958602
PMCPMC5225798
OpenAlexW2560039702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.